GGrantIndex
← Leaderboards

Yury Miller

University Of California, San Diego

Google Scholar ↗PubMed ↗ORCID ↗
$23,938,186
Attributed
$28,556,204
Total exposure
15
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY2006–25
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,556,204 · 15

By mechanism

R01$14,085,557 · 7
P01$6,833,841 · 5
R35$6,510,000 · 1
R21$750,154 · 1
R33$376,652 · 1

Top collaborators

Most similar at University Of California, San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Inflammation”

Research focus

InflammationInflammatoryMacrophageMediatingCholesterolInflammatory ResponseCellsProteinsAtherosclerosisIn VivoAnimal ModelTlr4 GeneMembrane MicrodomainsCell MembraneApolipoprotein A-ITissuesArterial Fatty StreakBinding ProteinsGenesMouse ModelBlood VesselsLesionMyocardial InfarctionSignal Transduction

Grant awards (58)

Macrophage Inflammarafts and Mitochondrial Dysfunction in Atherosclerosis$781,558
R01 · FY2025 · HL · contact PI
Reversing Microglial Inflammarafts and Mitochondrial Dysfunction in Alzheimer's Disease$753,317
R01 · FY2025 · AG · contact PI
Role of TLR4-lipid rafts in nociception$702,049
R01 · FY2025 · NS
Role of TLR4-lipid rafts in nociception$801,239
R01 · FY2024 · NS
Macrophage Inflammarafts and Mitochondrial Dysfunction in Atherosclerosis$789,998
R01 · FY2024 · HL · contact PI
Reversing Microglial Inflammarafts and Mitochondrial Dysfunction in Alzheimer's Disease$781,587
R01 · FY2024 · AG · contact PI
AIBP therapy$930,000
R35 · FY2023 · HL · contact PI
Reversing Microglial Inflammarafts and Mitochondrial Dysfunction in Alzheimer's Disease$789,121
R01 · FY2023 · AG · contact PI
AIBP therapy$930,000
R35 · FY2022 · HL · contact PI
Project 2: Cholesterol Regulation of Inflammatory Macrophages in Atherosclerosis$42,993
P01 · FY2022 · HL · contact PI
AIBP therapy$930,000
R35 · FY2021 · HL · contact PI
AIBP and regulation of neuropathic pain$443,771
R01 · FY2021 · NS · contact PI
Cholesterol Regulation of Inflammatory Macrophages in Atherosclerosis$351,231
P01 · FY2021 · HL · contact PI
AIBP therapy$930,000
R35 · FY2020 · HL · contact PI
AIBP and regulation of neuropathic pain$443,771
R01 · FY2020 · NS · contact PI
Reversal of preexisting neuropathic pain by spinal delivery of AIBP$376,652
R33 · FY2020 · NS · contact PI
Cholesterol Regulation of Inflammatory Macrophages in Atherosclerosis$354,006
P01 · FY2020 · HL · contact PI
AIBP therapy$930,000
R35 · FY2019 · HL · contact PI
AIBP and regulation of neuropathic pain$787,291
R01 · FY2019 · NS · contact PI
AIBP and regulation of neuropathic pain$443,771
R01 · FY2019 · NS · contact PI
Reversal of preexisting neuropathic pain by spinal delivery of AIBP$369,856
R21 · FY2019 · NS · contact PI
Cholesterol Regulation of Inflammatory Macrophages in Atherosclerosis$354,006
P01 · FY2019 · HL · contact PI
AIBP therapy$930,000
R35 · FY2018 · HL · contact PI
AIBP and regulation of neuropathic pain$443,771
R01 · FY2018 · NS · contact PI
Reversal of preexisting neuropathic pain by spinal delivery of AIBP$380,298
R21 · FY2018 · NS · contact PI
Cholesterol Regulation of Inflammatory Macrophages in Atherosclerosis$353,994
P01 · FY2018 · HL · contact PI
Morphology and Imaging Core$248,000
P01 · FY2018 · HL · contact PI
AIBP therapy$930,000
R35 · FY2017 · HL · contact PI
AIBP and regulation of neuropathic pain$443,771
R01 · FY2017 · NS · contact PI
Cholesterol Regulation of Inflammatory Macrophages in Atherosclerosis$365,259
P01 · FY2017 · HL · contact PI
Morphology and Imaging Core$248,000
P01 · FY2017 · HL · contact PI
AIBP and Endothelial Function$519,631
R01 · FY2016 · HL · contact PI
Oxidized Lipids and Endotoxemia in Vascular Inflammation$466,947
P01 · FY2016 · HL · contact PI
Morphology and Imaging Core$248,000
P01 · FY2016 · HL · contact PI
AIBP and Endothelial Function$515,635
R01 · FY2015 · HL · contact PI
Oxidized Lipids and Endotoxemia in Vascular Inflammation$463,682
P01 · FY2015 · HL · contact PI
Morphology and Imaging Core$244,279
P01 · FY2015 · HL · contact PI
Oxidized Lipids and Endotoxemia in Vascular Inflammation$464,550
P01 · FY2014 · HL · contact PI
Zebrafish models of vascular inflammation and atherosclerosis$413,647
R01 · FY2014 · HL · contact PI
Morphology and Imaging Core$246,153
P01 · FY2014 · HL · contact PI
Oxidized Lipids and Endotoxemia in Vascular Inflammation$453,556
P01 · FY2013 · HL · contact PI
Zebrafish models of vascular inflammation and atherosclerosis$400,562
R01 · FY2013 · HL · contact PI
Oxidized Lipids and Endotoxemia in Vascular Inflammation$502,328
P01 · FY2012 · HL · contact PI
Zebrafish models of vascular inflammation and atherosclerosis$419,459
R01 · FY2012 · HL · contact PI
Morphology Core$282,955
P01 · FY2012 · HL · contact PI
Zebrafish models of vascular inflammation and atherosclerosis$417,565
R01 · FY2011 · HL · contact PI
Morphology Core$286,548
P01 · FY2011 · HL · contact PI
Zebrafish models of vascular inflammation and atherosclerosis$412,575
R01 · FY2010 · HL · contact PI
Early Forms of Oxidized LDL, TLRs and Atherosclerosis$375,049
R01 · FY2010 · HL · contact PI
Morphology Core$281,243
P01 · FY2010 · HL · contact PI
Zebrafish models of vascular inflammation and atherosclerosis$457,677
R01 · FY2009 · HL · contact PI
Early Forms of Oxidized LDL, TLRs and Atherosclerosis$375,049
R01 · FY2009 · HL · contact PI
Morphology Core$281,243
P01 · FY2009 · HL · contact PI
Early Forms of Oxidized LDL, TLRs and Atherosclerosis$237,970
R01 · FY2009 · HL · contact PI
Early Forms of Oxidized LDL, TLRs and Atherosclerosis$375,049
R01 · FY2008 · HL · contact PI
Morphology Core$294,868
P01 · FY2008 · HL · contact PI
Early Forms of Oxidized LDL, TLRs and Atherosclerosis$375,049
R01 · FY2007 · HL · contact PI
Early Forms of Oxidized LDL, TLRs and Atherosclerosis$385,625
R01 · FY2006 · HL · contact PI